HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of ETB receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443.

Abstract
We used Ro 46-8443, non-peptidic antagonist selective of endothelin ETB receptors, to study the role of ETB receptors in rat hypertension models. In normotensive rats, Ro 46-8443 decreased blood pressure, but in SHR and DOCA rats, it induced a pressor effect, due to blockade of ETB-mediated release of nitric oxide since L-NAME prevented it. In rats rendered hypertensive by chronic L-NAME, Ro 46-8443 did not induce a pressor but depressor effect. Thus, in DOCA rats and SHR, Ro 46-8443 reveals a predominant influence of endothelial 'vasorelaxant' ETB receptors, while in normotensive rats the prevailing role of ETB receptors seems to be in mediating a vasoconstrictor tone.
AuthorsM Clozel, V Breu
JournalFEBS letters (FEBS Lett) Vol. 383 Issue 1-2 Pg. 42-5 (Mar 25 1996) ISSN: 0014-5793 [Print] England
PMID8612787 (Publication Type: Journal Article)
Chemical References
  • Endothelin Receptor Antagonists
  • Peptides, Cyclic
  • Pyrimidines
  • Receptor, Endothelin B
  • Receptors, Endothelin
  • Ro 46-8443
  • Sulfonamides
  • Viper Venoms
  • sarafotoxins s6
  • Arginine
  • Nitric Oxide Synthase
  • cyclo(Trp-Asp-Pro-Val-Leu)
  • NG-Nitroarginine Methyl Ester
Topics
  • Animals
  • Arginine (analogs & derivatives, pharmacology)
  • Blood Pressure (drug effects)
  • Endothelin Receptor Antagonists
  • Hypertension (physiopathology)
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Peptides, Cyclic (pharmacology)
  • Pyrimidines (pharmacology)
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Receptor, Endothelin B
  • Receptors, Endothelin (physiology)
  • Sulfonamides (pharmacology)
  • Viper Venoms (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: